SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Pharmaceutical Economics and Policy
0 references·7 citing·37 second hop
Pharmaceutical Economics and Policy (1998)Pharmaceutical Economics and PolicyCorporate Investment Relationships and the Search for Innovations: An Examination of Startups’ Search Shift Toward Incumbents (2021)Corporate Investment Relation…A competition‐based explanation of collaborative invention within the firm (2013)A competition‐based explanati…The Irish pharmaceutical industry over the boom period and beyond (2009)The Irish pharmaceutical indu…Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration (2007)Strategic Entry Deterrence an…Understanding Philip Morris’s pursuit of US government regulation of tobacco: Table 1 (2005)Understanding Philip Morris’s…PUBLIC POLICY SOURCES (2004)PUBLIC POLICY SOURCESGradual Incorporation of Information: Pharmaceutical Stocks and the Evolution of President Clinton’s Health Care Reform (2001)Gradual Incorporation of Info…Good News and Bad News: Representation Theorems and Applications (1981)The Theory of Industrial Organization (1988)Theory of Industrial Organization. (1989)The Relative Importance of Actual and Potential Competition: Empirical Evidence From the Pharmaceuticals Market (2003)Games Hospitals Play: Entry Deterrence in Hospital Procedure Markets (2005)Competition in Health Care Markets11We wish to thank participants at the Handbook of Health Economics meeting in Lisbon, Portugal, Pedro Pita Barros, Rein Halbersman, and Cory Capps for helpful comments and suggestions. Misja Mikkers, Rein Halbersma, and Ramsis Croes of the Netherlands Healthcare Authority graciously provided data on hospital and insurance market structure in the Netherlands. David Emmons kindly provided aggregates of the American Medical Association's calculations of health insurance market structure. Leemore Dafny was kind enough to share her measures of market concentration for the large employer segment of the US health insurance market. All opinions expressed here and any errors are the sole responsibility of the authors. No endorsement or approval by any other individuals or institutions is implied or should be inferred. (2011)A resource‐based view of the firm (1984)Firm Resources and Sustained Competitive Advantage (1991)Firm resources and sustained competitive advantage (2004)Knowledge mobilization in the face of imitation: Microfoundations of knowledge aggregation and firm‐level innovation (2020)A Bird in the Hand is Worth Two in the Bush: Technology Search Strategies and Competition Due to Import Penetration (2021)Knowledge diversity and technological innovation: The moderating role of top management teams (2024)Case Study Research: Design and Methods (1984)Archival Strategies and Techniques (1993)Tobacco industry documents: treasure trove or quagmire? (2000)Motivation of chemical industry social responsibility through Responsible Care (2006)Tobacco's Tipping Point: The Master Settlement Agreement as a Focusing Event (2006)The Role of Corporate Credibility in Legitimizing Disease Promotion (2008)The Second Industrial Divide (1985)Commodity Chains and Global Capitalism. (1995)Global production networks and the analysis of economic development (2002)Ageing with Smartphones in Ireland (2021)Event Studies in Economics and Finance (1997)The Econometrics of Financial Markets (1997)“Read My Lips … ”: Does the Tax Rhetoric of Presidential Candidates Affect Security Prices? (2005)Cost of Capital for Pharmaceutical, Biotechnology, and Medical Device Firms (2012)The Econometrics of Financial Markets (2012)Financial Health Economics (2016)A Contribution to the Theory of Economic Growth (1956)On the mechanics of economic development (1988)Institutions, Institutional Change and Economic Performance (1991)Absorptive Capacity: A New Perspective on Learning and Innovation (1990)Exploration and Exploitation in Organizational Learning (1991)The Theory of Economic Development (2003)External knowledge sourcing, knowledge spillovers, and internal collaboration: The effects of intrafirm linkages on firm‐university co‐authorship linkages (2022)Corporate Venture Capital and Startup Outcomes: The Roles of Investment Timing and Multiple Corporate Investors (2023)The inside track: Entrepreneurs' corporate experience and startups' access to incumbent partners' resources (2024)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2007Strategic Entry Deterrence and the Behavior of Pharmaceutical Incumbents Prior to Patent Expiration118 cited
  • 2013A competition‐based explanation of collaborative invention within the firm73 cited
  • 2021Corporate Investment Relationships and the Search for Innovations: An Examination of Startups’ Search Shift Toward Incumbents52 cited
  • 2005Understanding Philip Morris’s pursuit of US government regulation of tobacco: Table 149 cited
  • 2009The Irish pharmaceutical industry over the boom period and beyond49 cited
  • 2001Gradual Incorporation of Information: Pharmaceutical Stocks and the Evolution of President Clinton’s Health Care Reform47 cited
  • 2004PUBLIC POLICY SOURCES12 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work